Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Scienture Holdings PE Ratio 2013-2024 | SCNX

Current and historical p/e ratio for Scienture Holdings (SCNX) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Scienture Holdings PE ratio as of November 05, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Scienture Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-05 7.83 0.56
2024-06-30 10.14 $13.98 0.73
2024-03-31 9.29 $12.38 0.75
2023-12-31 2.56 $-5.44 0.00
2023-09-30 3.47 $-6.94 0.00
2023-06-30 6.43 $-6.35 0.00
2023-03-31 2.18 $-5.40 0.00
2022-12-31 2.98 $-6.15 0.00
2022-09-30 8.36 $-6.00 0.00
2022-06-30 11.98 $-7.50 0.00
2022-03-31 20.48 $-10.34 0.00
2021-12-31 17.45 $-9.75 0.00
2021-09-30 36.41 $-8.40 0.00
2021-06-30 32.68 $-5.70 0.00
2021-03-31 38.75 $-1.95 0.00
2020-12-31 39.12 $-0.45 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.008B
Scienture Holdings Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture Holdings Inc., formerly known as TRxADE Health Inc., is based in TAMPA, FL.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.076B 30.43
Takeda Pharmaceutical (TAK) Japan $45.246B 9.42
Merck (MKKGY) Germany $21.635B 23.61
Astellas Pharma (ALPMY) Japan $20.630B 19.00
Sandoz Group AG (SDZNY) Switzerland $19.917B 0.00
United Therapeutics (UTHR) United States $17.089B 16.81
Summit Therapeutics (SMMT) United States $15.037B 0.00
Shionogi (SGIOY) Japan $12.633B 12.10
Neurocrine Biosciences (NBIX) United States $12.305B 32.58
Catalent (CTLT) United States $10.615B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.363B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.881B 7.30
Orion OYJ (ORINY) Finland $6.848B 19.25
Ionis Pharmaceuticals (IONS) United States $5.673B 0.00
Corcept Therapeutics (CORT) United States $5.463B 41.38
Crinetics Pharmaceuticals (CRNX) United States $4.627B 0.00
PTC Therapeutics (PTCT) United States $3.144B 0.00
Dyne Therapeutics (DYN) United States $2.873B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.606B 20.72
Arrowhead Pharmaceuticals (ARWR) United States $2.557B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.554B 14.73
Soleno Therapeutics (SLNO) United States $2.192B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.917B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.724B 0.00
Ocular Therapeutix (OCUL) United States $1.648B 0.00
Harrow (HROW) United States $1.625B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Xencor (XNCR) United States $1.505B 0.00
ARS Pharmaceuticals (SPRY) United States $1.485B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.460B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.436B 0.00
Ardelyx (ARDX) United States $1.355B 0.00
Enliven Therapeutics (ELVN) United States $1.323B 0.00
Indivior (INDV) United States $1.270B 5.17
Guardian Pharmacy Services (GRDN) United States $1.193B 0.00
Cassava Sciences (SAVA) United States $1.148B 0.00
Collegium Pharmaceutical (COLL) United States $1.077B 6.18
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.047B 0.00
Bioventus (BVS) United States $0.930B 29.44
Cronos Group (CRON) Canada $0.849B 0.00
Relay Therapeutics (RLAY) United States $0.797B 0.00
USANA Health Sciences (USNA) United States $0.743B 13.77
Ironwood Pharmaceuticals (IRWD) United States $0.717B 44.90
Tourmaline Bio (TRML) United States $0.689B 0.00
Exscientia (EXAI) United Kingdom $0.625B 0.00
Korro Bio (KRRO) United States $0.611B 0.00
Savara (SVRA) United States $0.596B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 50.98
Verve Therapeutics (VERV) United States $0.540B 0.00
OmniAb (OABI) United States $0.532B 0.00
Silence Therapeutics (SLN) United Kingdom $0.527B 0.00
Siga Technologies (SIGA) United States $0.517B 6.19
Altimmune (ALT) United States $0.500B 0.00
KalVista Pharmaceuticals (KALV) United States $0.486B 0.00
Xeris Biopharma Holdings (XERS) United States $0.486B 0.00
Larimar Therapeutics (LRMR) United States $0.470B 0.00
ProKidney (PROK) United States $0.469B 0.00
Zevra Therapeutics (ZVRA) United States $0.453B 0.00
4D Molecular Therapeutics (FDMT) United States $0.436B 0.00
Aquestive Therapeutics (AQST) United States $0.434B 0.00
Esperion Therapeutics (ESPR) United States $0.416B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Organogenesis (ORGO) United States $0.403B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.396B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Sage Therapeutics (SAGE) United States $0.363B 0.00
Lyell Immunopharma (LYEL) United States $0.317B 0.00
Aldeyra Therapeutics (ALDX) United States $0.313B 0.00
Avita Medical (RCEL) United States $0.296B 0.00
Heron Therapeutics (HRTX) United States $0.268B 0.00
Lexeo Therapeutics (LXEO) United States $0.265B 0.00
Nektar Therapeutics (NKTR) United States $0.258B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.255B 0.00
Acrivon Therapeutics (ACRV) United States $0.243B 0.00
Nature's Sunshine Products (NATR) United States $0.242B 16.54
Enanta Pharmaceuticals (ENTA) United States $0.239B 0.00
Pyxis Oncology (PYXS) United States $0.234B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.231B 0.00
Nanobiotix S.A (NBTX) France $0.206B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
MediWound (MDWD) Israel $0.192B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Achieve Life Sciences (ACHV) Canada $0.167B 0.00
Context Therapeutics (CNTX) United States $0.166B 0.00
Galectin Therapeutics (GALT) United States $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.158B 0.00
Cardiol Therapeutics (CRDL) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.152B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
VAXART, INC (VXRT) United States $0.130B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Fractyl Health (GUTS) United States $0.115B 0.00
AlloVir (ALVR) United States $0.114B 0.00
Century Therapeutics (IPSC) United States $0.113B 0.00
Journey Medical (DERM) United States $0.109B 0.00
Karyopharm Therapeutics (KPTI) United States $0.105B 0.00
OptiNose (OPTN) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Regulus Therapeutics (RGLS) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.097B 17.00
CASI Pharmaceuticals (CASI) China $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.085B 0.00
ElectroCore (ECOR) United States $0.082B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
ESSA Pharma (EPIX) Canada $0.075B 0.00
Prelude Therapeutics (PRLD) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Citius Pharmaceuticals (CTXR) United States $0.063B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Champions Oncology (CSBR) United States $0.056B 0.00
Protara Therapeutics (TARA) United States $0.054B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Inotiv (NOTV) United States $0.050B 0.00
VYNE Therapeutics (VYNE) United States $0.048B 0.00
Unicycive Therapeutics (UNCY) United States $0.047B 0.00
Carisma Therapeutics (CARM) United States $0.046B 0.00
DURECT (DRRX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
ProPhase Labs (PRPH) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.035B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
Lipocine (LPCN) United States $0.031B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
GlycoMimetics (GLYC) United States $0.025B 0.00
BioVie (BIVI) United States $0.023B 0.00
MEI Pharma (MEIP) United States $0.020B 0.71
Inhibikase Therapeutics (IKT) United States $0.020B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
Talphera (TLPH) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Addex Therapeutics (ADXN) Switzerland $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.35
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.12